Patients in the Veritac-2 study were randomized to receive a standard estrogen blocker called fulvestrant, or Arvinas' ...
Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...
Benchmark analyst Robert Wasserman maintained a Buy rating on Immunoprecise Antibodies Ltd. (NASDAQ:IPA) with a price target ...
The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...
VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...
Meeting is thrilled to announce that Morten Meldal, Nobel Laureate and Professor of Chemistry at the University of Copenhagen ...
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...
"We found that using leukemic cell lines can lead to misleading results in drug discovery," said Wilhelm. "These cell lines do not grow in the same way as cells taken from patients." The efficacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback